Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

FibroGen Inc. (FGEN)

46.69   -0.95 (-1.99%) 12-13 16:00
Open: 47.55 Pre. Close: 47.64
High: 48.49 Low: 46.55
Volume: 494,753 Market Cap: 4074M
FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 48.561 - 48.806 48.806 - 49.007
Low: 45.996 - 46.25 46.25 - 46.458
Close: 46.32 - 46.716 46.716 - 47.042

Technical analysis

as of: 2019-12-13 4:31:01 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 57.17     One year: 66.78
Support: Support1: 38.68    Support2: 32.33
Resistance: Resistance1: 48.95    Resistance2: 57.17
Pivot: 44.59
Moving Average: MA(5): 47.49     MA(20): 42.80
MA(100): 41.47     MA(250): 45.49
MACD: MACD(12,26): 2.46     Signal(9): 2.01
Stochastic oscillator: %K(14,3): 84.97     %D(3): 88.64
RSI: RSI(14): 65.76
52-week: High: 61.23  Low: 32.33  Change(%): 19.7
Average Vol(K): 3-Month: 80885  10-Days: 65069

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
FGEN has closed below upper band by 33.9%. Bollinger Bands are 102.9% wider than normal. The large width of the bands suggest high volatility as compared to FGEN's normal range. The bands have been in this wide range for 13 bars. This is a sign that the current trend might continue.

Headline News

2019-11-14
FIBROGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating FibroGen, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- #fibrogen--Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against FibroGen, Inc. (NASDAQ: FGEN) on behalf of FibroGen stockholders. Our investigation concerns whether FibroGen has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On November 4, 2019, Plainview LLC (“Plainview”) published a report questioning the safety and efficacy of

2019-11-13
Glancy Prongay & Murray LLP Announces Investigation on Behalf of FibroGen, Inc. Investors
LOS ANGELES--(BUSINESS WIRE)---- $FGEN--Glancy Prongay & Murray LLP Announces Investigation on Behalf of FibroGen, Inc. Investors

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 87.25
Shares Float (M) 80.77
% Held by Insiders 10.92
% Held by Institutions 66.88
Shares Short (K) 4130
Shares Short P. Month (K)

Stock Financials

EPS 0.460
Book Value (p.s.) 6.820
PEG Ratio
Profit Margin 11.81
Operating Margin 8.70
Return on Assets (ttm) 2.2
Return on Equity (ttm) 7.6
Qtrly Rev. Growth 14.3
Gross Profit (p.s.) -0.262
Sales Per Share
EBITDA (p.s.) 0.566
Qtrly Earnings Growth
Operating Cash Flow (M) -51.12
Levered Free Cash Flow (M) -68.08

Stock Valuations

P/E 101.50
P/E Growth Ratio -0.02
P/BV 6.85
P/S 11.27
P/CF -79.69

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.